Skip to main content
. 2022 Jan 27;327(7):1–10. doi: 10.1001/jama.2022.0204

Figure 2. Posttransplant Survival of Study Cohorts.

Figure 2.

Survival of concurrent transplants performed for COVID-19–associated acute respiratory distress syndrome and chronic end-stage lung diseases (non–COVID-19). The median post–lung transplant observation time was 351 days (95% CI, 318-397) for patients with COVID-19–associated acute respiratory distress syndrome and 488 days (95% CI, 429-552) for patients in the non–COVID-19 cohort.